effect of vitamin E on the prevention of acute renal injury in patients with leukemia
Phase 3
Not yet recruiting
- Conditions
- eukemia.Lymphoid leukemia
- Registration Number
- IRCT20190717044255N7
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Leukemia patients taking vincristine
Age 3 to 18 years
Exclusion Criteria
Suffering from chronic kidney disease
Allergy to vitamin E medicine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glomerular filtration rate (GFR). Timepoint: At entry into the study, 48 hours later, one week and one month after the start of treatment. Method of measurement: Creatinine clearance formula.
- Secondary Outcome Measures
Name Time Method Serum creatinine level. Timepoint: At entry into the study, 48 hours later, one week and one month after the start of treatment. Method of measurement: Laboratory measurement of serum creatinine level.